DK1890692T3 - Formuleringer af liponsyre og benzylesteren fra hyaluronsyre indenfor det farmaceutiske og kosmetiske område - Google Patents

Formuleringer af liponsyre og benzylesteren fra hyaluronsyre indenfor det farmaceutiske og kosmetiske område

Info

Publication number
DK1890692T3
DK1890692T3 DK06743042T DK06743042T DK1890692T3 DK 1890692 T3 DK1890692 T3 DK 1890692T3 DK 06743042 T DK06743042 T DK 06743042T DK 06743042 T DK06743042 T DK 06743042T DK 1890692 T3 DK1890692 T3 DK 1890692T3
Authority
DK
Denmark
Prior art keywords
formulations
pharmaceutical
benzyl ester
acid
cosmetic fields
Prior art date
Application number
DK06743042T
Other languages
Danish (da)
English (en)
Inventor
Carlo Soranzo
Doriana Senigaglia
Davide Bellini
Original Assignee
Fidia Advanced Biopolymers Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl
Application granted granted Critical
Publication of DK1890692T3 publication Critical patent/DK1890692T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK06743042T 2005-06-01 2006-05-24 Formuleringer af liponsyre og benzylesteren fra hyaluronsyre indenfor det farmaceutiske og kosmetiske område DK1890692T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000168A ITPD20050168A1 (it) 2005-06-01 2005-06-01 Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
PCT/EP2006/004914 WO2006128618A1 (en) 2005-06-01 2006-05-24 Formulations of lipoic acid and hyaluronic acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields

Publications (1)

Publication Number Publication Date
DK1890692T3 true DK1890692T3 (da) 2009-11-16

Family

ID=36950241

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06743042T DK1890692T3 (da) 2005-06-01 2006-05-24 Formuleringer af liponsyre og benzylesteren fra hyaluronsyre indenfor det farmaceutiske og kosmetiske område

Country Status (11)

Country Link
US (1) US8349355B2 (it)
EP (1) EP1890692B1 (it)
CA (1) CA2610305C (it)
DE (1) DE602006007995D1 (it)
DK (1) DK1890692T3 (it)
ES (1) ES2328399T3 (it)
IT (1) ITPD20050168A1 (it)
PL (1) PL1890692T3 (it)
PT (1) PT1890692E (it)
SI (1) SI1890692T1 (it)
WO (1) WO2006128618A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20072416A1 (it) 2007-12-21 2009-06-22 Sigea Srl Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali
IT1397246B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica
IT1397247B1 (it) * 2009-05-14 2013-01-04 Fidia Farmaceutici Nuovi agenti regolatori dell'attivita' citochinica
BR112012021179A2 (pt) * 2010-02-23 2015-09-15 Sebana Medical Ltd método para aprimorar a sobrevivência da gordura adiposa em um paciente que necessite da mesma, uso de eritropoietina e composição farmacêutica
IT1403886B1 (it) 2010-12-15 2013-11-08 Sigea Srl Uso di esteri lipoati di glicosamminoglicani in campo tricologico
US9765182B2 (en) * 2013-09-20 2017-09-19 The United States Of America, As Represented By The Secretary Of Agriculture Elastomer derived from epoxidized vegetable oil
PL3297626T3 (pl) * 2015-05-21 2021-12-13 Ophtalmis Kompozycja oftalmiczna zawierająca kwas liponowy i kwas hialuronowy
WO2016184998A1 (fr) 2015-05-21 2016-11-24 Ophtalmis Monaco Association d'acide lipoique et de taurine en tant qu'agent osmoprotecteur

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
IT1264530B (it) * 1992-07-31 1996-10-02 Crinos Industria Farmaco Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
US5709868A (en) 1995-09-20 1998-01-20 Perricone; Nicholas V. Lipoic acid in topical compositions
US5785959A (en) * 1996-08-16 1998-07-28 Revlon Consumer Products Corporation Nail strengthening compositions and a method for strengthening nails
EP0855396A1 (en) * 1997-01-22 1998-07-29 ASTA Medica Aktiengesellschaft Thioctic acid metabolites and methods of use thereof
US5965618A (en) * 1997-11-17 1999-10-12 Perricone; Nicholas V. Treatment of scar tissue using lipoic acid
IT1306679B1 (it) * 1999-06-29 2001-10-02 Fidia Advanced Biopolymers Srl Uso dei derivati dell'acido ialuronico per la preparazione dicomposizoni farmaceutiche e biomateriali per la prevenzione della
JP2001212170A (ja) * 2000-02-04 2001-08-07 Toyobo Co Ltd 創傷被覆材
FR2820635B1 (fr) * 2001-02-09 2005-01-21 Genevrier Lab Procede de preparation d'une creme a base d'acide hyaluronique
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
US20040105873A1 (en) * 2002-11-29 2004-06-03 Gupta Shyam K. Topical formulation including stabilized water-soluble and oil-soluble compositions
DE10258239A1 (de) * 2002-12-13 2004-06-24 Degussa Ag Formulierung enthaltend alpha-Liponsäure(-Derivate) als alleinigen Wirkstoff bei nichtchronischen alkoholinduzierten Intoxikationen
US20040191330A1 (en) * 2003-03-31 2004-09-30 Keefe Candace R. Daily skin care regimen
US20040262368A1 (en) * 2003-06-26 2004-12-30 Haw Tan Tzyy Ball grid array solder joint reliability

Also Published As

Publication number Publication date
ES2328399T3 (es) 2009-11-12
US20090304758A1 (en) 2009-12-10
EP1890692B1 (en) 2009-07-22
CA2610305C (en) 2014-05-06
WO2006128618A1 (en) 2006-12-07
ITPD20050168A1 (it) 2006-12-02
SI1890692T1 (sl) 2009-12-31
PL1890692T3 (pl) 2009-12-31
PT1890692E (pt) 2009-09-10
CA2610305A1 (en) 2006-12-07
US8349355B2 (en) 2013-01-08
EP1890692A1 (en) 2008-02-27
DE602006007995D1 (de) 2009-09-03

Similar Documents

Publication Publication Date Title
DK1890692T3 (da) Formuleringer af liponsyre og benzylesteren fra hyaluronsyre indenfor det farmaceutiske og kosmetiske område
IL191998A (en) Pharmaceutical compounds and compositions of multicyclic amino acid history and their use
BRPI0913379A2 (pt) formulações farmacêuticas sólidas compreendendo bibw 2992
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
GB2431876B (en) Use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions
PL2172450T3 (pl) Nowe pochodne sulfonamidowe kwasu malonowego i ich zastosowanie farmaceutyczne
NO20075628L (no) Farmasøytiske formuleringer
NO20054969D0 (no) 2-cyanopropansyreamid- og esterderivater og deres anvendelse
BRPI0810439A2 (pt) Formulações farmacêuticas contendo derivados de ácido lipóico
BRPI0810928A2 (pt) "composição farmacêutica"
IL196169A0 (en) Bile acid derivatives and pharmaceutical compositions containing the same
ATE517081T1 (de) Hydroxamsäureester und deren pharmazeutische verwendung
HK1131557A1 (en) Glyceryl and glycol acid compounds
ATE482957T1 (de) Arylessigsäure- und esterderivate und deren verwendung als entzündungshemmende mittel
IL208497A0 (en) Pharmaceutical compositions containing erythropoietin and derivatives thereof
DK1968990T3 (da) Vandopløselig benzoazepinforbindelse og farmaceutisk sammensætning deraf
NO20054662D0 (no) Farmasoytisk sammensetning omfattende 5-metyl-2-2'-(klor-6'-fluoranilin)fenyleddiksyre
DK1803732T3 (da) Peptider og derivater af APL-TYPE af HSP60 og famaceutiske sammensætninger
ITFI20050239A1 (it) Idrossammati come inibitori dell'istone deacetilasi e formulazioni farmaceutiche che li contegono
DK1798234T3 (da) Farmaceutisk sammensætning omfattende temozolomidester
ITMI20051416A1 (it) Composizioni cosmetiche contenenti acido ialuronico e colostro
DK2474528T3 (da) Antineoplastiske forbindelser og farmaceutiske kompositioner deraf
EP1703904A4 (en) TAXOID-FATTY ACID CONJUGATES AND PHARMACEUTICAL COMPOSITIONS THEREOF
EP1803452A4 (en) ESTER DERIVATIVE AND ITS PHARMACEUTICAL USE THEREOF
DK1784174T3 (da) Famaceutisk sammensætning omfattende gabapentin